TechU Ventures
VC Fund
New York, United States
TechU Ventures is a VC fund in New York focused on Biotechnology and Health Care. TechU invests in platform technologies that harness complex science and engineering breakthroughs for enduring global impact.We write patient checks that propel technologists with early capital and knowledgeable support.We scour the world’s leading universities, labs, and research centers for emerging technologies with wide-reachingimplications, structured to maximize lasting impact over momentary returns.Our interest spans continents and categories in search of transformative technology that generates distinct competitive advantages.At the helm are experienced entrepreneurs who contribute hard-earned funds and hard-won expertise to deliver the holistic support deep tech pioneers require.In short, we search for the foundations of our collective future.
- Total investments:
- 45
- Last investment:
- Lead investor:
- 9%
- Fund size:
- $11M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries TechU Ventures invests in
Stages TechU Ventures invests in
Countries TechU Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Khodadad Barookhian
|
|||
Investment Focus
Industry
- Biotechnology 14 (31%)
- Health Care 6 (13%)
- Machine Learning 6 (13%)
- Software 5 (11%)
- Computer 4 (9%)
Stage
- Seed 23 (51%)
- Series A 7 (16%)
- Funding Round 4 (9%)
- Pre-Seed 1 (2%)
- Series B 1 (2%)
Country
- United States 24 (53%)
- Canada 2 (4%)
- Switzerland 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Khodadad Barookhian
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Portal
|
Portal is a cell engineering platform firm that enables next generation cell engineering and cell analytics in research and clinical settings. | $9M / Seed / Jun 18, 2026 | |
Sound Health
|
Sound Health uses acoustic resonance to provide nasal relief. Its current product is an app that scans the face to map the bone structure and then a headband that plays music at personalized frequencies for 10 minutes. The headband is off the shelf and the sound levels are akin to wearing earpods. It envisions the headband to be over-the-counter(OTC) so it’s easily accessible to patients, whether prescribed by doctors or not. | $7M / Seed / Jul 24, 2024 | |
Alithea Genomics
|
Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis. The company provides technologies that use RNA barcoding and multiplexing methods to enable the analysis of many RNA samples within a single sequencing experiment. Its products support workflows for RNA sequencing, includinglibrary preparation methods designed for transcriptome profiling and gene expression studies. Alithea Genomics also offers reagents, protocols, and software tools that assist researchers in processing sequencing data and interpreting gene expression results. These technologies are used in academic and industry research settings to study biological processes, disease mechanisms, and cellular responses through transcriptomic analysis. | $3.2M / Seed / Mar 14, 2024 | |
BioLoomics
|
BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays. | $8.7M / Seed / Sep 19, 2023 | |
Liberum Biotech
|
Liberum offers next generation protein manufacturing. Taking advantage of our suite of proprietary molecular and hardware technologies, we bring speed, scalability and cost reduction to disrupt current biologics manufacturing practices. Our vision is to democratize access to the fruits of synthetic biology. | $1.8M / Seed / Jul 24, 2023 | |
Naveris
|
Naveris is a biotechnology company that provides highly sensitive blood tests for cancers to enable early diagnosis in the general asymptomatic population, real-time monitoring of response in patients undergoing treatment, and detection of cancer recurrence in patients in remission. The company's 3D biomimetic technology replicates themorphological, signaling, and cell lineage complexity of human tissues and tumors ex vivo. By empowering investigators to efficiently establish patient tumors ex vivo, its technology enables innovative designs for oncology clinical trials and precision medicine that seek to match the right therapies with the right patients.Naveris was founded in 2017 and is headquartered in Waltham, Massachusetts. | $33.4M / Series A / Sep 19, 2022 | |
Arpeggio Bio
|
Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work. | $17M / Series A / Sep 07, 2022 | |
Sydecar
|
Sydecar builds tools that remove the headache of organizing private investments -- so you can focus on making deals, not spreadsheets. Their lightweight, powerful technology helps you to manage subscription docs, compliance, banking, tax reporting, and admin for all of your deals, of any size, in one place. | $8.3M / Seed / Apr 05, 2022 | |
|
Sound Health
|
Sound Health uses acoustic resonance to provide nasal relief. Its current product is an app that scans the face to map the bone structure and then a headband that plays music at personalized frequencies for 10 minutes. The headband is off the shelf and the sound levels are akin to wearing earpods. It envisions the headband to be over-the-counter(OTC) so it’s easily accessible to patients, whether prescribed by doctors or not. | $2M / Seed / Dec 27, 2021 | |
DropGenie
|
DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of discovery through the generation of standardized and compatible scientific information. | Seed / Oct 01, 2021 | |
| See all 45 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does TechU Ventures invest in?
TechU Ventures invests primarily in Biotechnology, Health Care and Machine Learning startups, most often at Seed and Series A stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact TechU Ventures?
Public channels for TechU Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TechU Ventures?
The team at TechU Ventures includes Khodadad Barookhian (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
